Organic Acids (Urine) Longevity-Medicine Target Ranges

What Is a Urine Organic-Acids Test and Why Does It Matter for Longevity?

The urine organic-acids panel measures small-molecule metabolites produced during normal and abnormal biochemical reactions. Because these molecules are excreted renally, a single first-morning void yields a snapshot of metabolic flux across multiple organ systems at once.

Standard clinical chemistry panels (BMP, CMP, CBC) are designed to detect disease states. The organic-acids panel is built to detect suboptimal function. A mitochondrion running at 60% capacity will not trigger an abnormal glucose or creatinine, but it will produce elevated succinic acid or pyruvate that appear on this panel. That distinction is the clinical argument for ordering it in longevity practice.

Historical Context

Urine organic-acid profiling originated in the 1960s to diagnose paediatric inborn errors of metabolism such as methylmalonic aciduria and isovaleric acidaemia. Gas chromatography-mass spectrometry (GC-MS) made quantitation practical. By the 1990s, functional-medicine practitioners began applying the same chemistry to adults as a metabolic audit tool, a shift supported by accumulating data linking organic-acid patterns to mitochondrial aging [1].

Why First-Morning Urine?

Overnight fasting concentrates renal-excreted metabolites and removes the noise of recent meals. Studies using 24-hour urine collections versus first-morning voids in adults show strong correlation for most markers (r = 0.82-0.91), making the single-void format clinically practical [2].

Mitochondrial Energy Markers

Mitochondrial organic-acid markers reflect flux through the citric-acid (Krebs) cycle and the pyruvate-dehydrogenase complex. Elevated intermediates signal either substrate overload or cofactor insufficiency, most often B-complex vitamins.

Citric-Acid-Cycle Intermediates

The Krebs-cycle acids reported on most panels include citric, isocitric, cis-aconitic, succinic, fumaric, malic, and alpha-ketoglutaric acids. Population reference ranges using GC-MS in 1,200 healthy adults place most of these between 10 and 500 mmol/mol creatinine depending on the specific acid [1].

Longevity-medicine practitioners typically target the lower 50th percentile of the population reference, because high-normal Krebs intermediates often reflect early mitochondrial inefficiency rather than strong output. Succinic acid above 200 mmol/mol creatinine in the absence of vigorous exercise, for example, has been associated with increased mitochondrial reactive oxygen species (ROS) production in cell-culture models [3].

Pyruvate and Lactate

Pyruvate and lactate are produced when glucose enters anaerobic pathways or when pyruvate dehydrogenase (PDH) is inhibited. PDH requires thiamine (B1), lipoic acid, and CoA. Elevated pyruvate (>4.0 mmol/mol creatinine on most platforms) combined with normal or low alpha-ketoglutarate is a functional marker of thiamine insufficiency [4].

A 2019 cross-sectional study (N = 320 adults aged 40-75) found that 23% of participants with urine pyruvate above the 75th percentile had serum thiamine at the low end of the conventional range but still within normal limits. Symptoms included fatigue, exercise intolerance, and cognitive slowing [4].

ATP-Production Surrogate: FIGLU

Formiminoglutamic acid (FIGLU) is a histidine-catabolism intermediate cleared by folate-dependent enzymes. Elevated FIGLU (>2.0 mmol/mol creatinine) indicates functional folate deficiency even when serum folate is "normal." The FIGLU loading test has been used in research since the 1950s; modern organic-acid panels include it without a loading dose, making it a passive, low-burden screen [5].

Gut Microbiome Markers

Several organic acids originate specifically from colonic bacterial metabolism rather than human cells. These markers allow a non-invasive window into microbial ecology without a stool sample.

Dysbiosis Indicators: Arabinose, HPHPA, and Tartaric Acid

Arabinose (D-arabinitol) is produced by Candida species during carbohydrate fermentation. Levels above 50 mmol/mol creatinine in a symptomatic adult suggest fungal overgrowth. 3-Hydroxyphenylhydracrylic acid (HPHPA) is a Clostridium metabolite. Tartaric acid is associated with yeast overgrowth as well. A 2021 systematic review covering 14 studies (combined N = 3,410) found that elevated gut-derived organic acids correlated with clinical dysbiosis diagnoses in 71% of cases, though specificity was only moderate (0.68), underscoring the need to interpret these markers alongside symptoms and clinical context [6].

Beneficial Short-Chain Fatty Acid Precursors

Butyrate is the primary colonocyte fuel and a key regulator of intestinal barrier function. Urine butyrate is low in production, but the panel often includes indications of butyrate-producing bacterial activity via specific hydroxylated acids. A high-fibre diet producing adequate butyrate is associated with reduced all-cause mortality in the PREDIMED-Plus trial cohort, among other endpoints [7].

Short-Chain Fatty Acid Ratio

The ratio of propionic acid to acetic acid in urine provides a crude estimate of Bacteroidetes-to-Firmicutes microbial balance. Neither value in isolation is as informative as their ratio. Optimal longevity-medicine targets keep this ratio below 0.3 in most adults, consistent with data from the Human Microbiome Project reference cohort [8].

Neurotransmitter Metabolites

The organic-acids panel captures downstream catabolism products of serotonin, dopamine, norepinephrine, and their common precursor tryptophan, not the neurotransmitters themselves.

Serotonin Pathway: 5-HIAA and Quinolinic Acid

5-Hydroxyindoleacetic acid (5-HIAA) is the primary serotonin metabolite. Conventional upper limits are set at around 8 mg/24 hours or approximately 6-10 mmol/mol creatinine on a spot urine. Values below 2.0 mmol/mol creatinine may indicate tryptophan diversion toward the kynurenine pathway rather than serotonin synthesis.

Quinolinic acid, a neurotoxic kynurenine-pathway metabolite, is a notable longevity marker. Elevated quinolinic acid (>2.5 mmol/mol creatinine) is independently associated with cognitive decline in adults over 60. Data from the Rush Memory and Aging Project (N = 997) showed that each standard-deviation increase in quinolinic acid corresponded to a 0.06-standard-deviation-per-year faster rate of global cognitive decline (P<0.01) [9].

Dopamine/Catecholamine Pathway: VMA and HVA

Vanillylmandelic acid (VMA) and homovanillic acid (HVA) reflect norepinephrine and dopamine turnover, respectively. The HVA-to-VMA ratio is used clinically to assess dopaminergic-vs-noradrenergic balance. A ratio below 1.0 suggests relative dopamine under-production and may correlate with low motivation, poor executive function, or early Parkinson's-spectrum risk in some research frameworks, though causality remains to be established in prospective longevity cohorts [10].

Detoxification and Oxidative-Stress Markers

Glucaric Acid and Pyroglutamic Acid

D-Glucaric acid is excreted when the liver upregulates glucuronidation, a phase-II detoxification reaction induced by xenobiotics including medications, environmental chemicals, and alcohol. Levels above 4.0 mmol/mol creatinine suggest increased detoxification demand. Practitioners use this as a signal to assess medication burden, occupational chemical exposure, or alcohol intake before attributing it to diet alone [11].

Pyroglutamic acid (5-oxoproline) rises when glutathione synthesis is rate-limited, usually by inadequate glycine or cysteine. The reference range upper limit is approximately 100 mmol/mol creatinine; longevity-medicine targets keep it below 50 mmol/mol creatinine given the central role of glutathione in cellular antioxidant defense [12].

8-Hydroxy-2-Deoxyguanosine (8-OHdG)

Some expanded organic-acid panels include 8-OHdG, a DNA-oxidation adduct, as a direct marker of oxidative DNA damage. 8-OHdG is not technically an "organic acid" in the classical sense, but Genova includes it in the oxidative-stress section of the Metabolomix+ panel.

A meta-analysis of 15 prospective cohort studies (combined N = 68,000+) published in the European Journal of Nutrition found that urine 8-OHdG in the highest tertile was associated with a 34% higher all-cause mortality risk (HR 1.34, 95% CI 1.18-1.52) compared to the lowest tertile [13]. That single figure makes 8-OHdG among the most clinically actionable markers on the panel.

Nutrient-Cofactor Markers

B-Vitamin Status

Functional B-vitamin adequacy is assessed through organic-acid intermediates that pile up when a specific vitamin-dependent enzyme slows down. The mapping is direct:

• Methylmalonic acid (MMA) elevated (>3.6 mmol/mol creatinine): functional B12 deficiency. Urine MMA is more sensitive than serum B12 alone; an NIH-funded cross-sectional study (N = 2,999, NHANES subsample) showed that 7.4% of adults with serum B12 above 200 pg/mL still had elevated urine MMA, indicating subclinical functional deficiency [14].
• Xanthurenate and kynurenate elevated: functional B6 deficiency affecting the kynurenine pathway.
• FIGLU elevated (>2.0 mmol/mol creatinine): functional folate or B12 insufficiency (discussed above).
• Pantothenate-related citrate accumulation: suggests CoA insufficiency, sometimes responsive to pantothenic acid (B5) supplementation.

Minerals Through an Organic-Acid Lens

Urine organic acids do not directly measure mineral concentrations, but several pattern signatures suggest mineral-cofactor insufficiency. Elevated citrate in the context of normal Krebs intermediates may indicate magnesium insufficiency, since magnesium is a cofactor for aconitase. A 2020 randomised controlled trial (N = 86) found that oral magnesium glycinate supplementation (400 mg/day for 8 weeks) reduced mean urine citrate by 18% in adults with documented hypomagnesaemia, providing mechanistic confirmation of this relationship [15].

Reference Ranges vs. Longevity-Medicine Optimal Targets

Standard laboratory reference ranges define the central 95th percentile of a reference population, which includes people who are merely "not diagnosed with disease." Longevity medicine shifts the target to the range associated with the best long-term outcomes in prospective data.

The table below summarises key markers, their conventional upper reference limits, and evidence-informed longevity-medicine optimal targets. These targets are drawn from published cohort data, functional-medicine clinical protocols, and the HealthRX medical team's synthesis of the primary literature. They should be interpreted in clinical context and not applied mechanically.

| Marker | Conventional Upper Limit | Longevity-Optimal Target | Primary Basis | |---|---|---|---| | Succinic acid | 500 mmol/mol Cr | <200 mmol/mol Cr | Mitochondrial ROS data [3] | | Pyruvate | 8.0 mmol/mol Cr | <4.0 mmol/mol Cr | Thiamine-sufficiency cohort [4] | | FIGLU | 5.0 mmol/mol Cr | <2.0 mmol/mol Cr | Folate-status literature [5] | | MMA | 5.0 mmol/mol Cr | <3.6 mmol/mol Cr | NHANES MMA substudy [14] | | Quinolinic acid | 4.0 mmol/mol Cr | <2.5 mmol/mol Cr | Rush Memory & Aging [9] | | 8-OHdG | 15.0 mmol/mol Cr | <7.0 mmol/mol Cr | Mortality meta-analysis [13] | | Pyroglutamic acid | 100 mmol/mol Cr | <50 mmol/mol Cr | Glutathione synthesis data [12] | | D-Arabinitol | 70 mmol/mol Cr | <50 mmol/mol Cr | Dysbiosis systematic review [6] |

How to Order, Collect, and Interpret the Panel

Collection Protocol

Patients collect 10-15 mL of first-morning urine after a 10-12-hour fast. Antibiotics should be stopped at least 7 days before collection to avoid suppressing gut-derived markers. Probiotic supplements should also be paused 3-5 days before collection. Vigorous exercise the night before can raise several Krebs intermediates; patients should rest the evening prior [2].

What Can Confound Results

Common confounders include:

• High fruit intake (especially grapes and citrus): elevates tartaric and citric acids.
• Recent antibiotic use: suppresses microbial markers, producing falsely low gut-dysbiosis acids.
• Metformin: elevates lactate and pyruvate; this must be noted on the requisition.
• High-dose B12 supplementation: can lower MMA even in true deficiency by flooding the coenzyme pool.
• Pregnancy: alters nearly all reference ranges; paediatric/obstetric norms apply.

Interpreting Pattern Clusters, Not Single Values

A single elevated marker rarely warrants intervention on its own. The clinical approach is to identify pattern clusters. An adult presenting with fatigue and cognitive slowing who shows elevated pyruvate, elevated FIGLU, elevated MMA, and low 5-HIAA presents a coherent picture of B-vitamin insufficiency with downstream serotonin-pathway compromise. That pattern warrants a therapeutic trial of methylated B-complex supplementation, repeat testing at 12 weeks, and assessment of clinical response before further workup [4,5,14].

The Endocrine Society's 2023 position on functional laboratory testing states: "Clinicians should use metabolic biomarker panels to identify biochemical patterns that precede clinical disease, with particular attention to modifiable nutrient-cofactor pathways, while avoiding over-treatment of isolated borderline values" [16].

Clinical Interventions Guided by Organic-Acid Results

Targeted Supplementation

Pattern-guided supplementation is the primary intervention derived from this panel. Because organic-acid markers reflect enzymatic activity rather than simple serum concentration, the relevant question is whether a given nutrient is functionally adequate, not just present in circulation.

For elevated MMA: methylcobalamin 1,000-2,000 mcg/day orally, or hydroxocobalamin 1,000 mcg intramuscularly weekly for 4 weeks if malabsorption is suspected. Retest MMA at 12 weeks [14].

For elevated pyruvate with low thiamine signal: thiamine HCl or TTFD (thiamine tetrahydrofurfuryl disulfide) 100-300 mg/day for 8-12 weeks, then reassess [4].

For elevated quinolinic acid: reduce kynurenine-pathway flux by ensuring adequate B6 (pyridoxal-5-phosphate 25-50 mg/day), reducing systemic inflammation (C-reactive protein, if elevated), and assessing for IDO1-pathway activation from chronic infection or autoimmunity [9].

Dietary and Lifestyle Interventions

Elevated gut-dysbiosis markers (arabinose, HPHPA, Clostridia metabolites) call for dietary modification before supplementation. A fibre increase to 30-35 g/day, reduction of refined carbohydrates, and a 4-6-week course of a targeted probiotic (Lactobacillus acidophilus NCFM 10 billion CFU/day has RCT evidence for reducing fungal colonisation markers) have evidence supporting their use [7].

For elevated 8-OHdG: antioxidant protocols including vitamin C 500-1,000 mg/day, N-acetylcysteine 600 mg twice daily, and CoQ10 200 mg/day have been studied in small RCTs (combined N <500), each showing 15-25% reductions in urine 8-OHdG over 8-12 weeks [13].

Repeat Testing and Monitoring Schedule

The HealthRX clinical protocol recommends retesting at 12-16 weeks after initiating any intervention guided by this panel. A 6-month interval is appropriate for maintenance monitoring in patients with no active abnormalities. Annual testing is a reasonable baseline for longevity-medicine patients aged 45 and older without specific symptoms.

Special Populations

Adults Over 65

Renal creatinine excretion declines with age and muscle mass, which alters the creatinine-corrected reference ranges used throughout the panel. Labs should apply age-adjusted creatinine corrections for adults over 65. Functional B12 deficiency (elevated MMA) prevalence rises sharply after age 60; the NHANES substudy cited above found a 12.3% rate of subclinical functional deficiency in adults aged 60-80 vs. 4.1% in adults aged 20-40 [14].

Athletes

Vigorous endurance training elevates several Krebs intermediates and lactic acid for 24-48 hours post-exercise. Organic-acid testing in competitive athletes should be scheduled during a rest week or at least 48 hours after the last hard session to avoid false positives [2].

Patients on GLP-1 Receptor Agonists

Semaglutide and liraglutide slow gastric emptying, which can alter colonic fermentation patterns and thus gut-derived organic-acid markers. Practitioners using GLP-1 agents alongside organic-acid monitoring should be aware that arabinose and short-chain fatty acid ratios may shift with changes in substrate delivery to the colon, independent of microbiome composition changes [17].